companydata.dkBIODANE PHARMA A/S: Financial statements 2019
CVR: 28310102
BIODANE PHARMA A/S (CVR 28310102) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,508,453 and a net result of DKK 256,752 compared with DKK -467,077 the year before. That is an increase of 49.2% compared with the year before. Equity amounted to DKK 1,658,980. The solvency ratio was 93.5%. The company had 1 employee in the financial year.
- Gross Profit
- 1,508,453 kr.
- Profit/Loss
- 256,752 kr.
- Equity
- 1,658,980 kr.
- Total Assets
- 1,775,138 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 1.5 mio. | 257 t. | 1.7 mio. | 1 |
| 2018 | - | 1 mio. | -467 t. | 1.4 mio. | 1 |
| 2017 | - | 968 t. | 103 t. | 1.9 mio. | 1 |
| 2016 | - | 747 t. | 33 t. | 767 t. | 1 |
| 2015 | - | 438 t. | -253 t. | 734 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
BIODANE PHARMA A/S has published its annual report for 2018. Gross profit came to DKK 1,010,830, and the net result was DKK -467,077.
About BIODANE PHARMA A/S
BIODANE PHARMA A/S is a Danish company of the type Aktieselskab based in Gesten, founded in 2004. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Gunner Kreutzer Jakobsen. The company is owned by BIODAN A/S. In 2025, the company reported a gross profit of DKK 2,534,166 and a net result of DKK 182,862 compared with DKK 1,651,356 the year before. Equity amounted to DKK 2,505,002.